IVI and Yonsei University College of Medicine’s IIID to collaborate in vaccine R&D
IVI Director General, Dr. Jerome Kim (right) shakes hands with Prof. Jeon-Soo Shin from Yonsei University College of Medicine’s IIID as they exchange MOU at IVI on February 12, 2019.
On February 12 IVI exchanged a memorandum of understanding with the Institute of Immunology and Immunological Diseases (IIID), part of Yonsei University’s College of Medicine. With this agreement, the two organizations are establishing a collaborative relationship in research and development of vaccines in order to help achieve the common goal of accelerating safe, effective, and affordable vaccines for people in developing countries and global health. The Yonsei University College of Medicine is affiliated with Yonsei University Severance Hospital, one of the largest general hospitals in Korea. IIID, which is currently led by Prof. Jeon-Soo Shin, conducts basic and clinical research, thereby contributing to the development of the immunology and vaccine field, and training research professionals specializing in infection, immunology, and immunological diseases.
From left: Prof. Jae Myun Lee and Prof. Jeon-soo Shin from Yonsei University College of Medicine; Director General Dr. Jerome Kim, and Acting Deputy Director General of Science Dr. Manki Song from IVI
Attendees discuss strategies of mutual cooperation to accelerate vaccine R&D during the MOU signing ceremony.